Racial variation in clinical and immunological manifestations of systemic sclerosis

Journal of Rheumatology

Volumn 33, Issue 2, 2006, Pages 263-268

  Nietert, Paul J ^a,c   Mitchell, Holly C ^b   Bolster, Marcy B ^b   Shaftman, Stephanie R ^a   Tilley, Barbara C ^a   Silver, Richard M ^b  

^a Department of Biostatistics Bioinformatics and Epidemiology ^*  (United States)

^b Shelby Biomedical Research Building 302   (United States)

^c Center for Health Care Research   (United States)

Author keywords

Autoantibodies; Clinical manifestations; Continental population groups; Demographics; Racial disparities; Scleroderma

Indexed keywords

CENTROMERE ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CAUCASIAN; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; GENDER; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RACE DIFFERENCE; SYSTEMIC SCLEROSIS; UNIVERSITY HOSPITAL;

ADULT; AFRICAN AMERICANS; AGE OF ONSET; AUTOANTIBODIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SOUTH CAROLINA;

EID: 32144452902     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nietert PJ, Silverstein MD, Silver RM. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rheumatol 2001;28:2031-7.
2. Nietert PJ, Silver RM. Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA. J Rheumatol 2003;30:1238-43.
3. McNeilage LJ, Youngchaiyud U, Whittingham S. Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989;32:54-60.
4. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC. Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992;35:216-8.
5. Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998;114:801-7.
6. Steen VD, Conte C, Owens GR, Medsger TA, Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994;37:1283-9.
7. Kuwana M, Kaburaki J, Arnett FC, et al. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999;42:465-74.
8. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA, Jr. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994;37:902-6.
9. Reveille JD, Fischbach M, McNearney T, et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 2001;30:332-46.
10. Wolf RE, Adamashvili IM, Gelder FB, Hall VC, Fraser PA, McDonald JC. Soluble HLA-I in rheumatic diseases. Hum Immunol 1998;59:644-9.
11. Clements PJ, Furst DE. Systemic sclerosis, 2nd edition. Baltimore: Lippincott Williams & Wilkins; 2003.
12. Centers for Disease Control and Prevention [Internet]. Atlanta (GA): Eliminating racial and ethnic health disparities [Internet. Accessed 27 October 2005]. Available from http://www.cdc.gov/omh/AboutUs/disparities.htm
13. Lonzetti LS, loyal F, Raynauld JP, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
14. Steen VD, Medsger TA, Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
15. Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology Oxford 2004;43:461-6.
16. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997;40:441-5.
17. Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001;44:1359-62.
18. Kawaguchi Y, Tochimoto A, Ichikawa N, et al. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum 2003;48:186-92.